Literature DB >> 23075635

Rituximab in pemphigus.

Amrinder J Kanwar, Keshavamurthy Vinay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23075635     DOI： 10.4103/0378-6323.102354

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  5 in total

1.  Rituximab in Pemphigus: Road Covered and Challenges Ahead.

Authors:  Keshavamurthy Vinay; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

2.  Treatment of a Refractory Case of Chronic Bullous Disease of Childhood in a Five Year Old Child with Rituximab.

Authors:  Uma S Agarwal; Navneet K Randhawa; Arti Singh; Puneet Agarwal
Journal:  Indian Dermatol Online J       Date:  2021-11-22

3.  The Demographic Attributes, Clinical Features, and Optimal Management of 143 Patients with Pemphigus: A Retrospective Observational Study from a Tertiary Care Center of India.

Authors:  Vikram K Mahajan; Karaninder S Mehta; Jyotshna Sharma; Prabal Kumar; Pushpinder S Chauhan; Ravinder Singh; Sujaya Manvi; Sanket Vashist; Anuj Sharma; Anju L Sharma
Journal:  Indian Dermatol Online J       Date:  2022-03-03

4.  Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab.

Authors:  Debdeep Mitra; Anuj Bhatnagar; Gautam K Singh; Sunmeet Sandhu
Journal:  Indian Dermatol Online J       Date:  2022-03-03

5.  Biosimilars in pemphigus vulgaris.

Authors:  Sharmila Patil; Nidhi Sharma; Kiran Godse; Nitin Nadkarni
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.